Skip to main content

Stanford Prof Pays Investors In Defunct Biotech Nuredis $29m

Mintz Member Michael Gardener spoke to Pharmaphorum about a lawsuit filed against a Stanford University professor for misleading investors from the company. Michael was lead attorney for plaintiffs Alafi Capital, and commented, "The payment of the amount demonstrates that in California the law applies equally to elite professors as it does to ordinary defendants."


Pharma Phorum